English | Español
Patient Daily | Dec 23, 2025

Patient-focused approaches may improve success rates in neuroscience drug development
Patient Daily | Dec 23, 2025

Biogen and Stoke report promising long-term seizure reduction data for Dravet syndrome drug
Patient Daily | Dec 23, 2025

Dyne Therapeutics reports strong early results for DMD exon skipping therapy
Patient Daily | Dec 23, 2025

Thomas Jefferson University develops AI tool for non-invasive brain tumor diagnosis
Patient Daily | Dec 23, 2025

Bliksem Health founder: '340B hospitals provide less charity care than the national average'
Patient Daily | Dec 23, 2025

BioSpace highlights five impactful biopharma stories from a transformative 2025
Patient Daily | Dec 23, 2025

Trump administration policies drive focus on US pharmaceutical manufacturing
Patient Daily | Dec 23, 2025

Free dental care extended up to age 25 for young people leaving state care

Trending
+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 17, 2026

Biogen, Sarepta, and Edgewise present new data at Muscular Dystrophy Association 2026 conference